Figures index

From

How to Develop Gluten-Free Foods for a Healthy Gut

Federico Morreale, Nicoletta Pellegrini

International Journal of Celiac Disease. 2015, 3(2), 44-47 doi:10.12691/ijcd-3-2-10
  • Figure 1. Percentual risk of type I EATL development in 5 years (details see in the text)
  • Figure 2. Percentual rate of type I EATL patients´survival in 5 years (details see in the text)
  • Figure 3. Type I EATL showing villous atrophy
  • Figure 4. Type I EATL: pleomorphic neoplastic cells showing high mitotic activity and admixture of eosinophils
  • Figure 5. Type I EATL neoplastic cells infiltrating residual mucosal epithelial structures
  • Figure 6. Type I EATL neoplastic cells showing surface and cytoplasmic CD3 positivity
  • Figure 7. Numerous neoplastic cell of type I EATL express CD30 positivity
  • Figure 8. Type II EATL: monomorphic small to medium-sized neoplastic cells with few intermingled dispersed eosinophils
  • Figure 9. Superficial mucosal exulceration in the type II EATL
  • Figure 10. CD8 positivity of neoplastic cells of type II EATL
  • Figure 11. CD56 positivity of neoplastic cells of type II EATL
  • Figure 12. CD2 positivity of neoplastic cells of type II EATL